Taken together, these results imply that HIFU suppresses the expression of miR-134 in melanoma cells to enhance CD86 expression, which enhances anti-tumor immunity by triggering IFN-γ and TNF-α secretion from lymphocytes. This evidence concerns the gene CD86 and neoplasm.